UnitedHealth Group Incorporated $UNH Shares Purchased by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 50.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 15,000 shares of the healthcare conglomerate’s stock after buying an additional 5,000 shares during the quarter. UnitedHealth Group accounts for about 3.4% of Sivik Global Healthcare LLC’s holdings, making the stock its 9th biggest holding. Sivik Global Healthcare LLC’s holdings in UnitedHealth Group were worth $5,506,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. LFG Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after purchasing an additional 27 shares during the last quarter. Synergy Financial Group LTD raised its position in UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 27 shares during the last quarter. Ares Financial Consulting LLC lifted its holdings in UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after buying an additional 28 shares in the last quarter. Hudock Inc. boosted its position in UnitedHealth Group by 1.0% in the 2nd quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock valued at $1,182,000 after buying an additional 28 shares during the last quarter. Finally, Rockland Trust Co. boosted its position in UnitedHealth Group by 1.1% in the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after buying an additional 29 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Down 0.2%

Shares of UnitedHealth Group stock traded down $0.61 during trading on Tuesday, hitting $377.91. 8,133,352 shares of the company were exchanged, compared to its average volume of 7,353,724. The firm has a market capitalization of $339.21 billion, a P/E ratio of 24.32, a price-to-earnings-growth ratio of 1.43 and a beta of 0.60. The firm’s fifty day moving average price is $388.03 and its 200 day moving average price is $381.81. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. During the same quarter in the previous year, the company earned $2.59 earnings per share. The business’s quarterly revenue was down .4% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 59.72%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Argus boosted their target price on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. TD Cowen decreased their price target on UnitedHealth Group from $430.00 to $402.00 and set a “hold” rating on the stock in a report on Friday. Truist Financial lifted their price objective on UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Jefferies Financial Group boosted their price objective on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Finally, Royal Bank Of Canada upped their target price on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $462.59.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, well above estimates of roughly $4.12–$4.14 and substantially higher than the year-ago result. Revenue of approximately $112.7 billion also exceeded expectations. UnitedHealth Group tops estimates, hikes profit outlook
• Positive Sentiment: Third-quarter operating earnings increased 52% to $6.6 billion, supported by lower medical costs, tighter cost controls and improved execution across the insurance and Optum businesses. Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, versus $18.15 in 2025. UnitedHealth raises 2026 earnings outlook
• Positive Sentiment: The results reinforce management’s turnaround strategy, including exiting unprofitable patient groups and improving operating discipline. Executives also suggested that investments in value-based care and artificial intelligence are beginning to contribute to performance. UnitedHealth: Huge Earnings Surprise
• Neutral Sentiment: Management indicated that Wall Street may be underestimating UnitedHealth’s 2027 earnings potential, but investors will likely need additional evidence that margin improvement can continue after the current recovery. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Negative Sentiment: Revenue was essentially flat year over year, with some reports showing a 0.4% decline, while Optum Health revenue slipped. Medical membership also fell, highlighting the trade-off between stronger margins and slower top-line growth. UnitedHealth’s Q3 2026 Sales Top Estimates
• Negative Sentiment: Although the earnings beat and guidance increase were significant, the initial enthusiasm faded, suggesting investors may have expected an even stronger outlook or more convincing evidence of sustained growth. UNH Earnings Beat and Raise Not Enough for Wall Street

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.